Status:
COMPLETED
Insulin Sensitivity, Irisin and Adipokines as Outcome Parameters in Patients Undergoing Cardiac Surgery
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborating Sponsors:
McGill University
Conditions:
Insulin Resistance
Diabetes Mellitus Type 2
Eligibility:
All Genders
18+ years
Brief Summary
BACKGROUND: Surgical injury and inflammation provoke a stereotypical stress response. Insulin resistance plays an intriguing role in these metabolic alterations and depends on the intensity of injury....
Detailed Description
see Information below
Eligibility Criteria
Inclusion
- Aged \>18 years
- Admission to the surgical intensive care unit after elective cardiac surgery (aortocoronary bypass and/or valve repair)
- Being capable of understanding and signing the consent form
Exclusion
- Blood glucose values requiring continuous insulin infusion preoperatively
- Ongoing selenium therapy
- Pregnancy
- Interventional valve repair
- Intraoperative hypothermic cardiac arrest
- Off-pump cardiac surgery
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
348 Patients enrolled
Trial Details
Trial ID
NCT02258698
Start Date
May 1 2013
End Date
December 1 2016
Last Update
February 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andrea Kopp Lugli
Basel, Canton of Basel-City, Switzerland, 4031